Melanin from nigerseed hulls attenuates psoriasis-like inflammation via its antioxidant and cytokine-modulatory mechanisms
Abstract
Psoriasis is a chronic, immune-mediated skin disorder marked by keratinocyte hyperproliferation, oxidative stress, and persistent inflammation. Herein, we demonstrate, melanin extracted from nigerseed hulls (NH melanin), a plant biopigment, as a therapeutic agent against Psoriasis. In a murine model of psoriasis, topical application of both native and hydrogel-formulated NH-melanin markedly ameliorated clinical symptoms, including erythema, epidermal thickening, and scaling. In histological examination, NH melanin treatment significantly reduced epidermal hyperplasia and normalized skin architecture. Mechanistically, NH melanin alleviated systemic inflammation by suppressing pro-inflammatory cytokines such as TNF-α, IL-6, and IL-17 with concomitant upregulation of antioxidant genes SLC7A11 and HMOX1, indicating the activation of redox-balancing pathways. These in vivo findings were further supported by in vitro analysis using keratinocytes, in which NH melanin reduced intracellular reactive oxygen species, an upstream activator of inflammation in psoriasis. Collectively, these findings identify NH melanin as a promising plant-derived antioxidant and anti-inflammatory agent in a preclinical model of psoriasis-like inflammation, warranting its further investigation as a potential topical anti-psoriatic therapeutics.